FRACQUAL

Novel therapeutic agents to improve bone quality during fracture repair

Coordinatore	LUNDS UNIVERSITET    more  Organization address address: Paradisgatan 5c city: LUND postcode: 22100 contact info Titolo: Prof. Nome: Matti Cognome: Ristinmaa Email: send email Telefono: 46462227987 Fax: +46 46 222 7370
Nazionalità Coordinatore	Sweden [SE]
Totale costo	100˙000 €
EC contributo	100˙000 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2011-CIG
Funding Scheme	MC-CIG
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-01-01   -   2015-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	LUNDS UNIVERSITET  Organization address address: Paradisgatan 5c city: LUND postcode: 22100 contact info Titolo: Prof. Nome: Matti Cognome: Ristinmaa Email: send email Telefono: 46462227987 Fax: +46 46 222 7370	SE (LUND)	coordinator	100˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Supporting this application will enhance the changes for a well-known Swedish biomechanics researcher to relocate to Lund University and suceed with her long term goal to establish her research activities in Sweden. The proposal includes the use of highly advanced technology (engineering and physics) to evaluate novel treatments for bone fractures (orthopedics). Hence, it is truely multidisciplinary and requires the involvement of engineers, physicists, biologists and orthopedic surgeons within the collaborating environments. Fracture repair is a complex process, where about 5-10% of all fractures lead to complications. Complications are especially high in elderly patients with osteoporosis, where more effective treatment options are needed. This project evaluates the effect of newly developed potent bone modulating drugs during fracture repair in osteoporotic animals. Two animal models have been developed and are in use; the bone chamber and the open fracture healing model in rats. The evaluation methods involve highly modern biophysical evaluation techniques in order to determine and evaluate the quality of the newly formed tissue, to assess the treatments clinical potential. Hence, the project applies newly developed technology to study fracture repair and evaluate bone quality, including vascularization (in vivo microCT), composition (Synchrotron FTIR) and structure (Synchrotron SAXS), of the newly formed tissue. A successful outcome would result in enhanced quality of life for many patients. Lund University has long experience in developing novel biological treatments of fracture repair, and excellent technical experimental facilities, including MAX-lab synchrotron facilities, Biomedical Imaging center and Center for Biomechanics at Lund University. Hence, the match between the fellow, the project and the location is excellent.'